| 注册
首页|期刊导航|新医学|尿液生物标志物在狼疮性肾炎预后评估中的作用

尿液生物标志物在狼疮性肾炎预后评估中的作用

黄碧瑶 李文根

新医学2025,Vol.56Issue(4):429-436,8.
新医学2025,Vol.56Issue(4):429-436,8.DOI:10.12464/j.issn.0253-9802.2024-0040

尿液生物标志物在狼疮性肾炎预后评估中的作用

Role of urinary biomarkers in the prognostic assessment of lupus nephritis

黄碧瑶 1李文根2

作者信息

  • 1. 汕头大学医学院附属梅州医院,广东 梅州 514000
  • 2. 梅州市人民医院风湿免疫科,广东 梅州 514000
  • 折叠

摘要

Abstract

Lupus nephritis(LN)is a major cause of mortality and morbidity in patients with systemic lupus erythematosus(SLE).Previous studies have shown that the pathological types of LN can transform,and these types serve as critical bases for formulating individualized treatment plans and predicting disease progression in SLE patients,thereby improving survival rates and quality of life.Renal pathology remains the"gold standard"for diagnosing LN and can be used to monitor disease progression and assess the therapeutic efficacy.However,renal pathology requires invasive renal biopsy,creating an urgent need for non-invasive biomarkers for LN diagnosis,disease activity monitoring,and treatment evaluation.Current research on biomarkers for disease monitoring primarily focuses on blood-derived biomarkers.In contrast,urinary biomarkers offer advantages such as ease of collection,non-invasiveness,and the ability for continuous short-term monitoring.Compared to renal biopsy and blood biomarkers,urinary biomarkers demonstrate significant advantages in diagnosing and monitoring LN.Emerging studies on urinary biomarkers for LN prognosis are on the rise.This review summarizes recent advances in the role of urinary biomarkers for LN prognosis assessment,thereby providing a reference for the clinical diagnosis and treatment of LN.

关键词

系统性红斑狼疮/狼疮性肾炎/尿液/生物标志物/预后

Key words

Systemic lupus erythematosus/Lupus nephritis/Urine/Biomarkers/Prognosis

引用本文复制引用

黄碧瑶,李文根..尿液生物标志物在狼疮性肾炎预后评估中的作用[J].新医学,2025,56(4):429-436,8.

基金项目

广东省医学科学技术研究基金(B2022263) (B2022263)

新医学

0253-9802

访问量0
|
下载量0
段落导航相关论文